We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Modified Ligand Helps Activate Cancer-Fighting T Cells

News   Apr 03, 2018 | Original story from the University of Connecticut

 
Modified Ligand Helps Activate Cancer-Fighting T Cells

This is an illustration showing interactions between components of the AH10-7 compound (yellow), an immune system antigen-presenting cell (gray), and an invariant natural killer T cell (green and blue) that spark activation of iNKT cells in 'humanized' mice. Credit: Jose Gascon/UConn

 
 
 

RELATED ARTICLES

Maturation Process of Natural Killer Cells Mapped

News

Notch signaling is necessary for the normal development and function of natural killer cells. This could be significant for the natural killer cells’ ability to fight cancer and infections.

READ MORE

Precise Engineering of Graphene Could Benefit Lab-on-a-chip Applications

News

A team of NYU researchers has solved a longstanding puzzle of how to build ultra-sensitive, ultra-small electrochemical sensors with homogenous and predictable properties by discovering how to engineer graphene structure on an atomic level.

READ MORE

Drug Seeks Out Receptors in Sarcoma Cells, Shrinks Tumors

News

A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE